Effect of pavanmuktasan and phalatrikadi kwath in madhumeha (diabetes mellitus type II)

A comparative randomised controlled clinical trial to study the effect of pavanmuktasana and phalatrikadi kwath in madhumeha (diabetes mellitus type II) - Nil

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103796

Enrollment

Registered

2026-02-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient with madhumeha symptoms. 2. Patient willing to participate in the study. 3. Raised FM/PM and RBS

Exclusion criteria

Exclusion criteria: 1. Age group less than 20 year and above 50 years. 2. Those with Complication of DM, carbuncles, vision impaiement, diabetic foot. 3. Patients with a history of CHD, CCF, High risk multi organ involvement, othe complications 4. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
Pawanmuktasan is better or phalatrikadi kwath is better to controll madhumeha.Timepoint: 60 days (Follow up done every 15 days)	—

Secondary

Measure	Time frame
NillTimepoint: 60 days	—

Countries

India

Contacts

Public ContactProf ANUPAM PATHAK

Tantia university sri ganganagar

drpathakanupam@gmail.com9414985631

Outcome results